Carocell Bio’s leadership team has extensive global experience in drug development and is committed to developing new medicines for patients with inflammatory diseases

Carocell Bio executive team

Dr Mike Davies MD, FRCRS, FRSPSG
Chief Executive Officer

  • Over 25 years’ global executive leadership experience in drug development in pharma (Pfizer, AstraZeneca, Shire) and biotech
  • Expertise in early-stage development and taking medicines from ideation to the market
  • Founder of Carocell Bio

John Nicholson

  • International experience in the pharmaceutical and chemical industries
  • Funded and managed Analytical Services companies
  • Advisory Board member of the UK North West Business Fund
  • Previous Chairman Gentronix
john nicholson biotech

Ann R. Mackey
Chief Financial Officer

  • Successful track record of leadership, launching operational initiatives, attracting talented managers, and developing effective teams.
  • Experienced with capital markets, corporate structuring, acquisitions, and venture capital.

Carocell Bio Advisory Team

Professor Fadi Issa
Consultant Burns and Plastic Surgeon

Buckinghamshire Healthcare NHS Trust Hospital & Health Care, Aylesbury , Buckinghamshire

fadi issa

Professor Yvonne Perrie
Scientific Advisor

 Internationally recognised expert in the field of liposomesand particulate drug delivery research.

yvonne perry

Professor Antony Sedgwick PHD
Scientific Advisor

Experienced biotech executive with over 40 years of experience in the sector

tony sedgwick

Carocell Bio Support team

Graham Combe
Business Development Director

graham combe

Priya Kalia, BSc, PhD
Director of Communications 

priya khalia

Dave Black
Digital Marketing Director

dave black

Ruth James, AAC
Financial Advisor


Jane Davies
Clinical Coordinator

jane davies